‘It is difficult to imagine anything more shocking or upsetting…’
(Joshua Paladino, Liberty Headlines) The Food and Drug Administration signed a contract on July 25 to obtain “fresh” human fetal tissue from aborted babies for the purpose of creating “humanized mice” with an operable “human immune system.”
The FDA paid $15,900 to Advanced Bioscience Resources, a non-profit company near San Francisco Bay, CNS News reported.
The contract will expire on July 25, 2019.
The Family Research Council called on the Housing Appropriations Committee to pass a bill that would prohibit the Department of Health and Human Services from paying for fetal tissue from aborted babies.
“It is difficult to imagine anything more shocking or upsetting than the U.S. government soliciting bids from traffickers in the remains of infant victims of abortion,” said Cathy Ruse, Family Research Council’s senior fellow for legal studies.
The fetal tissue contract is for ongoing research at the FDA.
“Fresh human tissues are required for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system,” an FDA notice said.
The Congressional Research Service assured the public that fetal tissue was from “elective abortions.”
“The U.S. Food and Drug Administration is committed to ensuring that its research is conducted responsibly, conforms with all legal requirements, and meets the highest ethical standards,” the FDA said in a statement.
The FDA also made a similar argument to Planned Parenthood, saying “research involving human fetal tissue accounts for a very small fraction of the FDA’s total research.”
This is the eighth contract the FDA has signed with ABR.
Seven contracts explicitly discussed human fetal tissue.
“Every part of this transaction is a tragedy,” Ruse said. “A woman is driven to abort her baby, too often by coercion or abandonment, and there in the shadows is a government contractor waiting to tear apart the baby’s body to deliver pieces in exchange for payment.”